News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
181 Results
Type
Article (9)
Press Release (172)
Section
Business (72)
Deals (13)
Drug Development (18)
FDA (1)
Job Trends (3)
News (95)
Policy (2)
Tag
Alliances (10)
Approvals (1)
Bankruptcy (1)
Best Places to Work (2)
Cancer (4)
Clinical research (11)
Compensation (5)
Data (1)
Diagnostics (1)
Earnings (28)
Events (32)
Executive appointments (4)
FDA (2)
Funding (1)
Healthcare (4)
IPO (13)
Layoffs (2)
Mergers & acquisitions (1)
Non-profit (1)
Northern California (1)
Ovarian cancer (2)
People (39)
Phase I (9)
Phase II (7)
Preclinical (5)
Regulatory (2)
Series A (1)
Southern California (21)
United States (31)
Date
Last 7 days (2)
Last 30 days (4)
Last 365 days (43)
2025 (12)
2024 (39)
2023 (25)
2022 (42)
2021 (41)
2020 (19)
2019 (3)
Location
Asia (3)
California (21)
Europe (2)
New York (1)
North Carolina (2)
Northern California (1)
Pennsylvania (3)
Southern California (21)
Washington State (5)
181 Results for "zentalis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zentalis Pharmaceuticals to Participate in Upcoming March 2025 Investor Conferences
February 25, 2025
·
1 min read
Layoffs
Zentalis Cuts 40% of Staff as it Eyes Phase II Readout For Lead Asset
The move is part of a strategic restructuring aimed at getting azenosertib to the market for patients with gynecological malignancies.
January 29, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development
January 28, 2025
·
7 min read
Press Releases
Zentalis Pharmaceuticals Announces Key Management Appointments
December 13, 2024
·
6 min read
Biotech Beach
Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Zentalis ® Pharmaceuticals, Inc. today announced that Zentalis management is scheduled to participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference on June 5, 2024, at 4:00 p.m. ET.
May 30, 2024
·
2 min read
Press Releases
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2025
February 4, 2025
·
2 min read
Press Releases
Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
January 29, 2025
·
13 min read
Drug Development
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
Zentalis ® Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the following studies of azenosertib: the Phase 1 ZN-c3-001 dose-escalation study in solid tumors.
June 18, 2024
·
7 min read
Press Releases
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 2, 2025
January 3, 2025
·
2 min read
Biotech Beach
Zentalis Pharmaceuticals to Participate in Upcoming March 2024 Investor Conferences
Zentalis® Pharmaceuticals, Inc. announced that Zentalis management will participate in several upcoming investor conferences.
February 28, 2024
·
2 min read
1 of 19
Next
